Journal article Open Access

Adverse effects of anticancer agents that target the VEGF pathway

Chen, Helen X.; Cleck, Jessica N.


JSON-LD (schema.org) Export

{
  "description": "Antiangiogenic agents that target the VEGF pathway have become an important part of standard therapy in multiple cancer indications. Although most adverse effects of VEGF inhibitors are modest and manageable, some are associated with serious and life-threatening consequences. This Review examines the toxicity profiles of anti-VEGF monoclonal antibodies and small-molecule inhibitors and considers the potential mechanisms of the adverse effects, risk factors, and the implications for patient management.", 
  "license": "http://creativecommons.org/publicdomain/zero/1.0/legalcode", 
  "creator": [
    {
      "@type": "Person", 
      "name": "Chen, Helen X."
    }, 
    {
      "@type": "Person", 
      "name": "Cleck, Jessica N."
    }
  ], 
  "headline": "Adverse effects of anticancer agents that target the VEGF pathway", 
  "image": "https://zenodo.org/static/img/logos/zenodo-gradient-round.svg", 
  "datePublished": "2009-07-07", 
  "url": "https://zenodo.org/record/1233504", 
  "@context": "https://schema.org/", 
  "identifier": "https://doi.org/10.1038/nrclinonc.2009.94", 
  "@id": "https://doi.org/10.1038/nrclinonc.2009.94", 
  "@type": "ScholarlyArticle", 
  "name": "Adverse effects of anticancer agents that target the VEGF pathway"
}
144
133
views
downloads
Views 144
Downloads 133
Data volume 57.5 MB
Unique views 137
Unique downloads 119

Share

Cite as